Aortech Share Discussion Threads

[semper vigilans] 14/5/2019 09:12

With a bit of a rise in income to mitigate increased expenditure.

[landy90] 14/5/2019 09:07

Amt
I think you are right on year just ended but I would expect cash burn to increase as manufacturing and testing gets underway, the business model used has probably reduced the spend by more than 50%.

[amt] 14/5/2019 08:01

Cash burn only about half a million a year I calculate. So even without increase in sales about 4 or 5 years left.

[bones] 14/5/2019 08:00

Absolutely, CHF. The raise of 2.6M was in May 2018, so a year later, spent developing major new products in cardiac devices, they still have £2.4M. This is a huge achievement and testament to the efficiency of their partnership deals with VFT and RUA Medical who are fully aligned and motivated to succeed in these projects. The value of the existing licensing income is there for all to see.

The market should be really pleased that finance is not pressing. So many companies developing life sciences tap the market regularly, so it’s a boon to know that AOR will not be, certainly in the current phase.

[ny boy] 14/5/2019 07:59

Patience dear boy, no rush to make money, investing in a Company like this one s 5-10 years, stay patient and harvest in years to come.

(MSYS), my retire early, is starting to move up,(excellent update this morning) catch these acorns before they become oak trees. Dyor on all these plays.

[coolhandfluke] 14/5/2019 07:47

Good to see increase in earnings and that they are not burning through the new money raised.

[the stigologist] 14/5/2019 00:59

LOL all that crying over £5k

What a fekkin' loser

[nextlink] 13/5/2019 14:18

It will not be there forever.
I anticipate Spectacular gains within the year.
We saw significant progress in the update at the end of January.

[zoro9791] 13/5/2019 12:25

Course I have sold. Who the hell is wait ting for two years for an AIM company?You guys chasing rainbows here.I lost £5k here not a big one.Made back on other shares within a week.This is just a bottom drawer and will be there forever.

[the stigologist] 08/5/2019 01:16

Zero(BrainCells)9791

[bones] 07/5/2019 21:35

Are you still waiting for your 88p Zoro or did you sell out? We need to know your situation to judge where you are coming from.

It’s been 100% clear from day 1 that this is a 2 year project. Invest and forget.

[zoro9791] 07/5/2019 21:13

F..cl áll happening here. I told you so.

[nobbygnome] 26/4/2019 13:39

Chart looks good for a breakout....

[bones] 26/4/2019 13:36

Any positive information about progress on the two areas of development (grafts and heart valve) should release some portion of that latent value anticipated by Stockdale (now Shore Cap).

[the stigologist] 26/4/2019 12:43

Setting up very nicely just below recent highs after a Golden Cross

Coming up to 12 month anniversary of the deal and Initiation of the 12 month target price of a 'potentially conservative 400p'

I don't think the Brokers/Company at any fault for us not having got anywhere near that target yet, it's simply the small cap effect in a very illiquid and tough overall market environment.

[greedy rooster] 26/4/2019 12:19

I’ve taken a few more this morning. Newsflow due and shares look ready to rock and roll.

[bones] 23/4/2019 09:54

Thanks someuwin (assuming it is accurate!)

[someuwin] 22/4/2019 20:20

Good research bones.

[bones] 21/4/2019 21:12

The new name on the >3% shareholder list is J D Abell. My initial researches suggest it could be this chap, J David Abell:



He is now 77 years old but still seems to be the owner and CEO of Jourdan plc which was once on AIM (until 2009) and that company owned a couple of medical-related companies until selling them in 2016. These were Westfield Medical and Clinipak. They traded as Jourdan Medical and “...specialised in single-use sterilisation barrier packaging and other sterilisation products to the medical and healthcare industry...”

If this is the investor, it is easy to see why he would be interested in Aortech and may have heard about it through industry contacts perhaps? Whatever the case, it is reassuring to know that AOR has been given the nod by someone in the industry even if the investment is a small lump of Mr Abell’s fortune.

If it is not this person, then I apologise!

[langland] 21/4/2019 21:10

Interesting. Thanks for updating. The net result seems to be that some of Miton's have been taken up by Walker Crips. Seems little doubt that we are missing a few rns announcements. My holding is split more or less equally between Walker and Hargreaves

[bones] 21/4/2019 19:06

Aortech have updated their significant shareholders list on their website, as at 16th April 2019. Some significant changes from the last listing I had at Oct 18, yet there has been not one single RNS notifying changes across the 1% thresholds above 3% in that time. The system is in disrepute.

Apart from Miton Asset Management, I think the other “institutions” are effectively nominees for private investors so will move around with the market sentiment.

I’m not surprised to see Miton reduce as they have been selling down most of their small caps especially pre-Christmas when there was some panicky cashing out of their small cap funds.

Anyway, here is the new list and below that the old one. I’ve put the new one in the header.

At 16 April 2019
16.38% Walker Crips Stockbrokers (2,406,092)
5.87% Miton Asset Management (862,071)
5.24% Clive Titcomb and family interests (770,000)
4.60% Hargreaves Lansdown Asset Management (675,753)
4.37% Mr Gordon Wright (641,645)
3.99% Share Centre Investment Management (586,229)
3.70% Mr JD Abell (543,399)
3.46% Interactive Investor (507,890)
3.45% Mr Bill Brown (506,649)

At 15 October 2018
11.98% Walker Crips Stockbrokers (1,759,455)
8.86% Miton Asset Management (1,301,929)
5.99% Charles Stanley (879,664)
5.29% Interactive Investor (776,396)
5.17% Clive Titcomb and family interests (759,501)
4.73% Hargreaves Lansdown Asset Management (694,873)
4.37% Mr Gordon Wright (641,645)
3.77% Share Centre Investment Management (553,808)
3.45% Mr Bill Brown (506,649)

[ny boy] 17/4/2019 23:45

Happy holding, chart technicals look very positive, expecting great returns from these and (STX)

[the stigologist] 17/4/2019 10:52

Golden Cross and potentially setting up to go higher